Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Schaffer

Showing results (41-50 of 379) with videos related to

Pageof 38
Sort By:
Clinics in Plastic Surgery|August 15, 2000
The clinical spectrum of pigmented lesionsJ V Schaffer, J L Bolognia
Advances in Biochemical Engineering/Biotechnology|March 30, 2006
Advanced targeting strategies for murine retroviral and adeno-associated viral vectorsJulie H Yu, David V Schaffer
Neuromolecular Medicine|March 6, 2004
Neurogenesis and neuroadaptationDavid V Schaffer, Fred H Gage
Current Protocols in Stem Cell Biology|March 8, 2018
hPSC-derived Midbrain Dopaminergic Neurons Generated in a Scalable 3-D BiomaterialMaroof M Adil, David V Schaffer
Cell and Tissue Research|November 11, 2017
Influence of hippocampal niche signals on neural stem cell functions during agingKira Irving Mosher, David V Schaffer
Advances in Experimental Medicine and Biology|November 14, 2017
Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene EditingBenjamin E Epstein, David V Schaffer
Gene Therapy|September 24, 2005
Antiviral RNAi therapy: emerging approaches for hitting a moving targetJ N Leonard, D V Schaffer
Dermatology Online Journal|May 22, 2007
Pachyonychia congenita associated with median rhomboid glossitisJulie K Karen, Julie V Schaffer
Science Translational Medicine|June 18, 2010
Gene therapy takes a cue from HAART: combinatorial antiviral therapeutics reach the clinicPriya S Shah, David V Schaffer
Gene Therapy|February 1, 2013
Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectorsB-Y Hwang, D V Schaffer
Pageof 38

Showing results (41-50 of 379) with videos related to

Sort By:
Pageof 38
Clinics in Plastic Surgery|August 15, 2000
The clinical spectrum of pigmented lesionsJ V Schaffer, J L Bolognia
Advances in Biochemical Engineering/Biotechnology|March 30, 2006
Advanced targeting strategies for murine retroviral and adeno-associated viral vectorsJulie H Yu, David V Schaffer
Neuromolecular Medicine|March 6, 2004
Neurogenesis and neuroadaptationDavid V Schaffer, Fred H Gage
Current Protocols in Stem Cell Biology|March 8, 2018
hPSC-derived Midbrain Dopaminergic Neurons Generated in a Scalable 3-D BiomaterialMaroof M Adil, David V Schaffer
Cell and Tissue Research|November 11, 2017
Influence of hippocampal niche signals on neural stem cell functions during agingKira Irving Mosher, David V Schaffer
Advances in Experimental Medicine and Biology|November 14, 2017
Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene EditingBenjamin E Epstein, David V Schaffer
Gene Therapy|September 24, 2005
Antiviral RNAi therapy: emerging approaches for hitting a moving targetJ N Leonard, D V Schaffer
Dermatology Online Journal|May 22, 2007
Pachyonychia congenita associated with median rhomboid glossitisJulie K Karen, Julie V Schaffer
Science Translational Medicine|June 18, 2010
Gene therapy takes a cue from HAART: combinatorial antiviral therapeutics reach the clinicPriya S Shah, David V Schaffer
Gene Therapy|February 1, 2013
Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectorsB-Y Hwang, D V Schaffer
Pageof 38